Activin  ||| S:0 E:8 ||| NNP
Controls  ||| S:8 E:17 ||| NNP
Ethanol  ||| S:17 E:25 ||| NNP
Potentiation  ||| S:25 E:38 ||| NNP
of  ||| S:38 E:41 ||| IN
Inhibitory  ||| S:41 E:52 ||| NNP
Synaptic  ||| S:52 E:61 ||| NNP
Transmission  ||| S:61 E:74 ||| NNP
Through  ||| S:74 E:82 ||| NNP
GABAA  ||| S:82 E:88 ||| NNP
Receptors  ||| S:88 E:98 ||| NNP
and  ||| S:98 E:102 ||| CC
Concomitant  ||| S:102 E:114 ||| NNP
Behavioral  ||| S:114 E:125 ||| NNP
Sedation  ||| S:125 E:134 ||| NNP
Activin ||| S:134 E:141 ||| NNP
,  ||| S:141 E:143 ||| ,
a  ||| S:143 E:145 ||| DT
member  ||| S:145 E:152 ||| NN
of  ||| S:152 E:155 ||| IN
the  ||| S:155 E:159 ||| DT
transforming  ||| S:159 E:172 ||| JJ
growth  ||| S:172 E:179 ||| NN
factor-β  ||| S:179 E:188 ||| JJ
family ||| S:188 E:194 ||| NN
,  ||| S:194 E:196 ||| ,
exerts  ||| S:196 E:203 ||| JJ
multiple  ||| S:203 E:212 ||| JJ
functions  ||| S:212 E:222 ||| NNS
in  ||| S:222 E:225 ||| IN
the  ||| S:225 E:229 ||| DT
nervous  ||| S:229 E:237 ||| JJ
system ||| S:237 E:243 ||| NN
.  ||| S:243 E:245 ||| .
Originally  ||| S:245 E:256 ||| RB
identified  ||| S:256 E:267 ||| VBN
as  ||| S:267 E:270 ||| IN
a  ||| S:270 E:272 ||| DT
neurotrophic  ||| S:272 E:285 ||| NN
and  ||| S:285 E:289 ||| CC
-protective  ||| S:289 E:301 ||| JJ
agent ||| S:301 E:306 ||| NN
,  ||| S:306 E:308 ||| ,
increasing  ||| S:308 E:319 ||| VBG
evidence  ||| S:319 E:328 ||| NN
implicates  ||| S:328 E:339 ||| NNS
activin  ||| S:339 E:347 ||| VBP
also  ||| S:347 E:352 ||| RB
in  ||| S:352 E:355 ||| IN
the  ||| S:355 E:359 ||| DT
regulation  ||| S:359 E:370 ||| NN
of  ||| S:370 E:373 ||| IN
glutamatergic  ||| S:373 E:387 ||| NN
and  ||| S:387 E:391 ||| CC
GABAergic  ||| S:391 E:401 ||| JJ
neurotransmission  ||| S:401 E:419 ||| NN
in  ||| S:419 E:422 ||| IN
brain  ||| S:422 E:428 ||| NN
regions  ||| S:428 E:436 ||| NNS
associated  ||| S:436 E:447 ||| VBN
with  ||| S:447 E:452 ||| IN
cognitive  ||| S:452 E:462 ||| NN
and  ||| S:462 E:466 ||| CC
affective  ||| S:466 E:476 ||| JJ
functions ||| S:476 E:485 ||| NNS
.  ||| S:485 E:487 ||| .
To  ||| S:487 E:490 ||| TO
explore  ||| S:490 E:498 ||| VB
how  ||| S:498 E:502 ||| WRB
activin  ||| S:502 E:510 ||| JJ
impacts  ||| S:510 E:518 ||| NNS
on  ||| S:518 E:521 ||| IN
ethanol  ||| S:521 E:529 ||| JJ
potentiation  ||| S:529 E:542 ||| NN
of  ||| S:542 E:545 ||| IN
GABA  ||| S:545 E:550 ||| NNP
synapses  ||| S:550 E:559 ||| NN
and  ||| S:559 E:563 ||| CC
related  ||| S:563 E:571 ||| JJ
behavioral  ||| S:571 E:582 ||| JJ
paradigms ||| S:582 E:591 ||| NN
,  ||| S:591 E:593 ||| ,
we  ||| S:593 E:596 ||| PRP
used  ||| S:596 E:601 ||| VBD
an  ||| S:601 E:604 ||| DT
established  ||| S:604 E:616 ||| JJ
transgenic  ||| S:616 E:627 ||| JJ
model  ||| S:627 E:633 ||| NN
of  ||| S:633 E:636 ||| IN
disrupted  ||| S:636 E:646 ||| FW
activin  ||| S:646 E:654 ||| FW
receptor  ||| S:654 E:663 ||| FW
signaling ||| S:663 E:672 ||| FW
,  ||| S:672 E:674 ||| ,
in  ||| S:674 E:677 ||| IN
which  ||| S:677 E:683 ||| WDT
mice  ||| S:683 E:688 ||| NNS
express  ||| S:688 E:696 ||| VBP
a  ||| S:696 E:698 ||| DT
dominant-negative  ||| S:698 E:716 ||| JJ
activin  ||| S:716 E:724 ||| FW
receptor  ||| S:724 E:733 ||| FW
IB  ||| S:733 E:736 ||| FW
mutant  ||| S:736 E:743 ||| FW
( ||| S:743 E:744 ||| -LRB-
dnActRIB ||| S:744 E:752 ||| NNP
)  ||| S:752 E:754 ||| -RRB-
under  ||| S:754 E:760 ||| IN
the  ||| S:760 E:764 ||| DT
control  ||| S:764 E:772 ||| NN
of  ||| S:772 E:775 ||| IN
the  ||| S:775 E:779 ||| DT
CaMKIIα  ||| S:779 E:787 ||| JJ
promoter ||| S:787 E:795 ||| NN
.  ||| S:795 E:797 ||| .
Comparison  ||| S:797 E:808 ||| NN
of  ||| S:808 E:811 ||| IN
GABAA  ||| S:811 E:817 ||| NNP
receptor  ||| S:817 E:826 ||| NN
currents  ||| S:826 E:835 ||| NNS
in  ||| S:835 E:838 ||| IN
hippocampal  ||| S:838 E:850 ||| JJ
neurons  ||| S:850 E:858 ||| NN
from  ||| S:858 E:863 ||| IN
dnActRIB  ||| S:863 E:872 ||| JJ
mice  ||| S:872 E:877 ||| NNS
and  ||| S:877 E:881 ||| CC
wild-type  ||| S:881 E:891 ||| JJ
mice  ||| S:891 E:896 ||| NNS
showed  ||| S:896 E:903 ||| VBD
that  ||| S:903 E:908 ||| IN
all  ||| S:908 E:912 ||| DT
concentrations  ||| S:912 E:927 ||| NNS
of  ||| S:927 E:930 ||| IN
ethanol  ||| S:930 E:938 ||| JJ
tested  ||| S:938 E:945 ||| NNS
( ||| S:945 E:946 ||| -LRB-
30-150  ||| S:946 E:953 ||| NNP
mM ||| S:953 E:955 ||| NNP
)  ||| S:955 E:957 ||| -RRB-
produced  ||| S:957 E:966 ||| VBD
much  ||| S:966 E:971 ||| RB
stronger  ||| S:971 E:980 ||| JJR
potentiation  ||| S:980 E:993 ||| NN
of  ||| S:993 E:996 ||| IN
phasic  ||| S:996 E:1003 ||| JJ
inhibition  ||| S:1003 E:1014 ||| NN
in  ||| S:1014 E:1017 ||| IN
the  ||| S:1017 E:1021 ||| DT
mutant  ||| S:1021 E:1028 ||| JJ
preparation ||| S:1028 E:1039 ||| NN
.  ||| S:1039 E:1041 ||| .
In  ||| S:1041 E:1044 ||| IN
dentate  ||| S:1044 E:1052 ||| JJ
granule  ||| S:1052 E:1060 ||| JJ
cells  ||| S:1060 E:1066 ||| NNS
of  ||| S:1066 E:1069 ||| IN
dnActRIB  ||| S:1069 E:1078 ||| JJ
mice ||| S:1078 E:1082 ||| NNS
,  ||| S:1082 E:1084 ||| ,
tonic  ||| S:1084 E:1090 ||| VBG
GABA  ||| S:1090 E:1095 ||| NNP
inhibition  ||| S:1095 E:1106 ||| NN
was  ||| S:1106 E:1110 ||| VBD
more  ||| S:1110 E:1115 ||| RBR
pronounced  ||| S:1115 E:1126 ||| VBN
than  ||| S:1126 E:1131 ||| IN
in  ||| S:1131 E:1134 ||| IN
wild-type  ||| S:1134 E:1144 ||| JJ
neurons ||| S:1144 E:1151 ||| NN
,  ||| S:1151 E:1153 ||| ,
but  ||| S:1153 E:1157 ||| CC
remained  ||| S:1157 E:1166 ||| VBD
insensitive  ||| S:1166 E:1178 ||| VBN
to  ||| S:1178 E:1181 ||| TO
low  ||| S:1181 E:1185 ||| JJ
ethanol  ||| S:1185 E:1193 ||| NNS
( ||| S:1193 E:1194 ||| -LRB-
30  ||| S:1194 E:1197 ||| NNP
mM ||| S:1197 E:1199 ||| NNP
)  ||| S:1199 E:1201 ||| -RRB-
in  ||| S:1201 E:1204 ||| IN
both  ||| S:1204 E:1209 ||| DT
preparations ||| S:1209 E:1221 ||| NN
.  ||| S:1221 E:1223 ||| .
The  ||| S:1223 E:1227 ||| DT
heightened  ||| S:1227 E:1238 ||| JJ
ethanol  ||| S:1238 E:1246 ||| JJ
sensitivity  ||| S:1246 E:1258 ||| NN
of  ||| S:1258 E:1261 ||| IN
phasic  ||| S:1261 E:1268 ||| JJ
inhibition  ||| S:1268 E:1279 ||| NN
in  ||| S:1279 E:1282 ||| IN
mutant  ||| S:1282 E:1289 ||| JJ
hippocampi  ||| S:1289 E:1300 ||| NN
resulted  ||| S:1300 E:1309 ||| VBD
from  ||| S:1309 E:1314 ||| IN
both  ||| S:1314 E:1319 ||| DT
pre-  ||| S:1319 E:1324 ||| JJ
and  ||| S:1324 E:1328 ||| CC
postsynaptic  ||| S:1328 E:1341 ||| JJ
mechanisms ||| S:1341 E:1351 ||| NNS
,  ||| S:1351 E:1353 ||| ,
the  ||| S:1353 E:1357 ||| DT
latter  ||| S:1357 E:1364 ||| NN
probably  ||| S:1364 E:1373 ||| RB
involving  ||| S:1373 E:1383 ||| VBG
PKCɛ ||| S:1383 E:1387 ||| JJ
.  ||| S:1387 E:1389 ||| .
At  ||| S:1389 E:1392 ||| IN
the  ||| S:1392 E:1396 ||| DT
behavioral  ||| S:1396 E:1407 ||| JJ
level ||| S:1407 E:1412 ||| NN
,  ||| S:1412 E:1414 ||| ,
ethanol  ||| S:1414 E:1422 ||| VBD
produced  ||| S:1422 E:1431 ||| VBN
significantly  ||| S:1431 E:1445 ||| RB
stronger  ||| S:1445 E:1454 ||| JJR
sedation  ||| S:1454 E:1463 ||| NN
in  ||| S:1463 E:1466 ||| IN
dnActRIB  ||| S:1466 E:1475 ||| JJ
mice  ||| S:1475 E:1480 ||| NNS
than  ||| S:1480 E:1485 ||| IN
in  ||| S:1485 E:1488 ||| IN
wild-type  ||| S:1488 E:1498 ||| JJ
mice ||| S:1498 E:1502 ||| NNS
,  ||| S:1502 E:1504 ||| ,
but  ||| S:1504 E:1508 ||| CC
did  ||| S:1508 E:1512 ||| VBD
not  ||| S:1512 E:1516 ||| RB
affect  ||| S:1516 E:1523 ||| VB
consumption  ||| S:1523 E:1535 ||| NN
of  ||| S:1535 E:1538 ||| IN
ethanol  ||| S:1538 E:1546 ||| NN
or  ||| S:1546 E:1549 ||| CC
escalation  ||| S:1549 E:1560 ||| NN
after  ||| S:1560 E:1566 ||| IN
withdrawal ||| S:1566 E:1576 ||| NN
.  ||| S:1576 E:1578 ||| .
We  ||| S:1578 E:1581 ||| PRP
link  ||| S:1581 E:1586 ||| VBP
the  ||| S:1586 E:1590 ||| DT
abnormal  ||| S:1590 E:1599 ||| JJ
narcotic  ||| S:1599 E:1608 ||| JJ
response  ||| S:1608 E:1617 ||| NN
of  ||| S:1617 E:1620 ||| IN
dnActRIB  ||| S:1620 E:1629 ||| JJ
mice  ||| S:1629 E:1634 ||| NNS
to  ||| S:1634 E:1637 ||| TO
ethanol  ||| S:1637 E:1645 ||| VB
to  ||| S:1645 E:1648 ||| TO
the  ||| S:1648 E:1652 ||| DT
excessive  ||| S:1652 E:1662 ||| JJ
potentiation  ||| S:1662 E:1675 ||| NN
of  ||| S:1675 E:1678 ||| IN
inhibitory  ||| S:1678 E:1689 ||| JJ
neurotransmission ||| S:1689 E:1706 ||| NN
.  ||| S:1706 E:1708 ||| .
Our  ||| S:1708 E:1712 ||| PRP$
study  ||| S:1712 E:1718 ||| NN
suggests  ||| S:1718 E:1727 ||| VBZ
that  ||| S:1727 E:1732 ||| DT
activin  ||| S:1732 E:1740 ||| JJ
counteracts  ||| S:1740 E:1752 ||| JJ
oversedation  ||| S:1752 E:1765 ||| NN
from  ||| S:1765 E:1770 ||| IN
ethanol  ||| S:1770 E:1778 ||| NN
by  ||| S:1778 E:1781 ||| IN
curtailing  ||| S:1781 E:1792 ||| VBG
its  ||| S:1792 E:1796 ||| PRP$
augmenting  ||| S:1796 E:1807 ||| JJ
effect  ||| S:1807 E:1814 ||| NN
at  ||| S:1814 E:1817 ||| IN
GABA  ||| S:1817 E:1822 ||| NNP
synapses.Neuropsychopharmacology  ||| S:1822 E:1855 ||| NNP
advance  ||| S:1855 E:1863 ||| NN
online  ||| S:1863 E:1870 ||| NN
publication ||| S:1870 E:1881 ||| NN
,  ||| S:1881 E:1883 ||| ,
27  ||| S:1883 E:1886 ||| CD
January  ||| S:1886 E:1894 ||| NNP
2016 ||| S:1894 E:1898 ||| CD
;  ||| S:1898 E:1900 ||| :
doi ||| S:1900 E:1903 ||| FW
: ||| S:1903 E:1904 ||| :
10.1038 ||| S:1904 E:1911 ||| CD
/ ||| S:1911 E:1912 ||| CD
npp.2015.372 ||| S:1912 E:1924 ||| CD
.  ||| S:1924 E:1926 ||| .
